reviewing changes in general practice, medical records and the development of computing in the NHS, including primary care. A description of computing hardware forms the next stretch and is the weakest in the book, being superficial and having some minor inaccuracies. Almost a derailment here. Now steam is up and we flash past the computerassisted medical record and its components. On to such well known visiting spots as the age/sex register and repeat prescriptions. On through costs and the uses of computers in other clinical parts of the Health Service. A brief stop at 'Blueprint for Acquisition' (chapter 8). Well worth a revisit. A quick dash past confidentiality to journey's end with summary and conclusions, where the costs and benefits of using computers are made more explicit.
Not a trip for the experienced traveller, but a very useful journey for those wondering what computing in primary care involves. The chapters fall into three general groups. One group is concerned with the drug treatment of specific conditions such as angina, hypertension, myocardial infarction, arrhythmia and infective endocarditis; some of these chapters also include useful reviews of the relevant pathophysiology. Another group of chapters reviews the clinical pharmacology of classes of drugs such as diuretics, betablockers, calcium antagonists, antiarrhythmic drugs, parenteral nitroglycerine and inotropic agents. The third group of chapters discuss certain therapeutic approaches, some better established than othersvasodilator drugs in heart failure, thrombolytic therapy in myocardial infarction, platelet suppressive drugs and anticoagulation in valvular heart disease. One other chapter, in some ways the one of most interest, is an account of adrenergic receptors and their therapeutic implications.
As the editor points out, there is some overlap in coverage of drugs looked at from clinical, pharmacological and therapeutic points of view. Chapters on the clinical pharmacology of diuretics and beta-blockers, however well written, can provide no tingle of expectation in 1984. The book also is, it should be understood, not one of therapeutics and hence does not to any extent attempt to put drug treatment into the context of non-pharmacological therapeutic approaches or discuss indications for drug use in detail. Nonetheless this book can be recommended for what it was intendeda review of the currently available drugs used in cardiovascular disease. As a bonus it provides glimpses of future approaches of exciting potential.
B I HOFFBRAND

Consultant Physician Whittington Hospital, London
Progress in Migraine Research, vol 2 F C Rose (ed) pp 292 £35 ISBN 0-272-79734-0 London: Pitman 1984 This volume contains a selection of papers presented at the September 1982 Migraine Trust International Migraine Symposium, held at Charing Cross Hospital, London. So what progress has there been in migraine research as revealed in the pages of this volume? Despite the restatements of old themes (for example, dietary migraine, serotonin and platelets, prostoglandins, thermography, etc.) this volume undoubtedly contains some interesting papers that might have been enhanced by an edited version of the discussions which followed each paper.
Published proceedings of symposia often provide a useful source for excellent reviews of a topic and two of note to be found here are by Dr E Bickerstaff on 'Complicated Migraine' and by Dr S P Hunt on 'Pain and Peptides'. The contributions are neatly grouped into sections on clinical aspects, neurochemistry, pathogenesis and therapeutics, and as with all the volumes in this series it is well produced and contains few printing errors. As a compilation of current research endeavours in migraine research there are few omissions, yet reading it merely emphasizes how far we are from understanding the aetiology of this condition.
CHRISTOPHER KENNARD
Consultant Neurologist
The There are often controversies in the use of drugs, and this Maudsley Monograph is about one of them -dependency on tranquillizers. That dependency can occur when psychotropic drugs are misused is accepted by everyone, but there is less certainty concerning the. nature of the problem when patients prefer to continue medication when only low doses have been used, albeit for a long time.
